Vera Therapeutics, Inc. - CL A (VERA)

Historical Portfolio Holders from Q2 2021 to Q2 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / CL A
Shares, excl. options Q1 2024
51.3 M
Holdings value Q1 2024
$2.21 B
Value change Q1 2024
+$475 M
Grand Portfolio weight change Q1 2024
+0.001%
Number of holders
155
Number of buys Q1 2024
1
Number of sells Q1 2024
-1
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
92337R101
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 4.55 K $165 K -$277 K $36.22 2
2024 Q1 51.3 M $2.21 B +$475 M $43.12 155
2023 Q4 41.3 M $636 M +$44.7 M $15.38 93
2023 Q3 39.3 M $538 M +$9.59 M $13.71 83
2023 Q2 38.1 M $612 M +$42.6 M $16.05 78
2023 Q1 37.4 M $290 M +$138 M $7.76 69
2022 Q4 21.2 M $411 M -$8.11 M $19.35 56
2022 Q3 21.5 M $459 M +$18.8 M $21.31 54
2022 Q2 20.4 M $277 M +$7.92 M $13.61 47
2022 Q1 19.5 M $457 M +$130 M $23.49 49
2021 Q4 14.1 M $375 M +$10.6 M $26.72 37
2021 Q3 14.7 M $252 M +$4.18 M $17.35 31
2021 Q2 14.5 M $186 M +$186 M $13.25 21